Search Results
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
August, 2024
August 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jul
anal cancer
Jul 25, 2024, 00:17 |
Blog
How to improve collection and analysis of Overall Survival data in oncology clinical trials - AACR
AACR (American Association for Cancer Research) shared on LinkedIn: "A recent perspective paper in Clinical…
Jul 24, 2024, 15:04 |
Insight
Arunah Chandran: Capacity assessment tool by ACCI for cancer care in India
Arunah Chandran, Public Health Officer at IARC - International Agency for Research on Cancer, shared a…
Jul 24, 2024, 07:43 |
Blog
Considerations to improve collection and analysis of overall survival data in oncology clinical trials - AACR
AACR (American Association for Cancer Research) shared a post on LinkedIn: ''A new perspective paper…
Jul 24, 2024, 03:52 |
Insight
Piotr Wysocki: The type of immunotherapy-related adverse event impacts the outcomes of anti-cancer immunotherapy
Piotr Wysocki recently posted on LinkedIn: “Understanding the co-occurrence patterns of immune-related adverse events (irAEs) across…
Jul 24, 2024, 01:01 |
Blog
Timothée Olivier: Interim data of early phase results from novel RAS inhibitor in pancreatic cancer
Timothée Olivier, Medical Oncologist at HUG – Geneva University Hospitals, shared his previous post on X,…
Jul 24, 2024, 00:59 |
Insight
Luca Licata: The fate of immunotherapy trials in breast cancer
Marco Mariani, Resident in Medical Oncology at San Raffaele Scientific Institute, shared a post on X…
Jul 23, 2024, 00:17 |
Insight
The number of cancer survivors is rising in the US
Yüksel Ürün shared a post on X about a recent paper by Emily Tonorezos et…
Jul 22, 2024, 23:16 |
Blog
Outcomes Among Racial and Ethnic Minority Patients With Advanced Cancers
Yuji Uehara, Medical Oncologist at National Cancer Center Hospital East, Komagome Hospital, shared a post…
Jul 22, 2024, 23:08 |
Blog
Yuksel Urun: Breast cancer risk factors strongest evidence
Yuksel Urun shared on X: ''Breast Cancer Risk Factors. Strongest evidence for: parity, age at first…
Jul 22, 2024, 07:05 |
Insight
Acalabrutinib, venetoclax, and obinutuzumab in relapsed/refractory CLL: final efficacy and ctDNA analysis of the CLL2-BAAG trial
Mazyar Shadman, Associate Professor of Medical Oncology at Fred Hutch Cancer Center, shared on X about…
10
11
12
13
14
All:
916
Posts:
111 - 120
CityU-AFCR Symposium on Precision Medicine and Digital Medicine
New management team at St. Anna Children's Hospital
Key Inspirational Moments with WHO Director at the Olympic Games
Remembering Susan Wojcicki, Honoring a Legacy of Leadership and Technological Innovation
MASCC24 Highlights: The Ideal Location for Care Varies According to Disease, Patient and Family Characteristics
Facebook
RSS Feed
Twitter
Linkedin
Youtube